During the corresponding time, Biolife Solutions Inc recorded a revenue increase by 11.98 % year on year, sequentially revenue grew by 3.53 %. While revenue at the Biolife Solutions Inc 's corporate clients
Biolife Solutions Inc's Comment on Sales, Marketing and Customers
The company provides products and services to customers involved in maintaining the health and function of biologic material during sourcing, manufacturing, and distribution. It operates as a bioproduction products and services business supporting multiple steps in the biologic material manufacturing and delivery process. Its portfolio includes biopreservation media and cell processing products, with expertise in cryobiology and the cell and gene therapy (CGT) workflow. The company serves an extensive customer base and pursues growth through innovation, partnerships, and acquisitions.
Recent transactions include the divestiture of SAVSU Cleo Technologies, LLC, a provider of smart shipping container products for temperature-sensitive biologics and pharmaceuticals, to Peli BioThermal LLC; the acquisition of PanTHERA CryoSolutions Inc., which holds patented Ice Recrystallization Inhibitor GEN 2 cryopreservation technology; and the divestiture of Custom Biogenic Systems (CBS), a producer of LN2 cryogenic freezers and dry storage accessory products, to Standex International Corporation.
Biolife Solutions Inc’s Comment on Sales, Marketing and Customers
The company provides products and services to customers involved in maintaining the health and function of biologic material during sourcing, manufacturing, and distribution. It operates as a bioproduction products and services business supporting multiple steps in the biologic material manufacturing and delivery process. Its portfolio includes biopreservation media and cell processing products, with expertise in cryobiology and the cell and gene therapy (CGT) workflow. The company serves an extensive customer base and pursues growth through innovation, partnerships, and acquisitions.
Recent transactions include the divestiture of SAVSU Cleo Technologies, LLC, a provider of smart shipping container products for temperature-sensitive biologics and pharmaceuticals, to Peli BioThermal LLC; the acquisition of PanTHERA CryoSolutions Inc., which holds patented Ice Recrystallization Inhibitor GEN 2 cryopreservation technology; and the divestiture of Custom Biogenic Systems (CBS), a producer of LN2 cryogenic freezers and dry storage accessory products, to Standex International Corporation.
Sources:
Biolife Solutions Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Biolife Solutions Inc’s corporate clients.
For your research, we’ve provided 9 tables on Biolife Solutions Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
